{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:20:35Z","timestamp":1795044035485,"version":"4.10.2"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Accessible tools for pharmacokinetic education and routine clinical pharmacokinetic analysis remain limited. Commercial software carries licensing costs and on the other hand existing open-source alternatives lack integrated workflows spanning study planning through bioequivalence assessment and are not user-friendly. We developed NCA Assistant, a browser-based application for non-compartmental pharmacokinetic analysis, bioequivalence testing, and power and sample size calculations within a single platform designed for pharmacokinetic research and teaching. NCA Assistant was designed with Anthropic Claude AI as coding assistant, with multi-expert prompting. The app was developed in R\/Shiny with a hub-based architecture connecting six workflow modules. Core computations rely on established R packages for non-compartmental analysis, power and sample size calculations and analysis of variance. For the interface, there was an emphasis for transparency through interactive visualization, configurable analysis settings and exportable audit trails. The application supports extravascular and intravenous dosing scenarios, handles both single-subject and batch analyses and accommodates standard crossover, replicate, and parallel bioequivalence designs.A dedicated visualization module generates publication-ready concentration\u2013time plots. Features include interactive terminal half-life review with point selection override and configurable thresholds for elimination half-life calculation. A validation package, consisting of draft validation documents and a validation script, accompanies the application and is supplied in the supplemental materials. NCA Assistant provides an accessible entry point for pharmacokinetic data analysis suitable for graduate training and routine clinical pharmacology applications, with extensibility for use in more regulated environments.<\/jats:p>","DOI":"10.1208\/s12248-026-01316-w","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:15:25Z","timestamp":1790630125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NCA Assistant: An Open-source R\/Shiny Interface for Non-compartmental Pharmacokinetic Analysis, Bioequivalence Testing and Study Planning"],"prefix":"10.1208","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2185-8201","authenticated-orcid":false,"given":"Rob","family":"ter Heine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"issue":"4","key":"1316_CR1","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1208\/s12248-013-9499-x","volume":"15","author":"B Davit","year":"2013","unstructured":"Davit B, Braddy AC, Conner DP, Yu LX. International guidelines for bioequivalence of systemically available orally administered generic drug products: a survey of similarities and differences. AAPS J. 2013;15(4):974\u201390.","journal-title":"AAPS J"},{"issue":"3","key":"1316_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1742-7843.2009.00518.x","volume":"106","author":"JAG Morais","year":"2010","unstructured":"Morais JAG, Lobato M. The new European Medicines Agency guideline on the investigation of bioequivalence. Basic Clin Pharmacol Toxicol. 2010;106(3):221\u20135.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"1316_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1208\/s12248-013-9470-x","volume":"15","author":"T Prueksaritanont","year":"2013","unstructured":"Prueksaritanont T, Chu X, Gibson C, Cui D, Yee KL, Ballard J, et al. Drug\u2013drug interaction studies: regulatory guidance and an industry perspective. AAPS J. 2013;15(3):629\u201345.","journal-title":"AAPS J"},{"key":"1316_CR4","unstructured":"Do XL, Yen DN, Tuan LA, Kawaguchi K, Kan M-Y, Chen N, editors. Multi-expert prompting improves reliability, safety and usefulness of large language models. Proceedings of the 2024 Conference on Empirical Methods in Natural Language Processing; 2024."},{"key":"1316_CR5","unstructured":"Chang W, Cheng J, Allaire J, Xie Y, McPherson J. Package \u2018shiny\u2019. See http:\/\/citeseerxistpsuedu\/viewdoc\/download. 2015."},{"key":"1316_CR6","unstructured":"R Core Team R: A language and environment for statistical computing 2026 [Available from: https:\/\/www.R-project.org\/."},{"issue":"1","key":"1316_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.12793\/tcp.2018.26.1.10","volume":"26","author":"H Kim","year":"2018","unstructured":"Kim H, Han S, Cho Y-S, Yoon S-K, Bae K-S. Development of R packages: \u2018NonCompart\u2019 and \u2018ncar\u2019 for noncompartmental analysis (NCA). Transl Clin Pharmacol. 2018;26(1):10\u20135.","journal-title":"Transl Clin Pharmacol."},{"key":"1316_CR8","unstructured":"Labes D, Sch\u00fctz H, Lang B, Labes MD. PowerTOST: Power and Sample Size for (Bio)Equivalence Studies 1.5\u20137 2025 [Available from: https:\/\/cran.r-project.org\/package=PowerTOST."},{"issue":"6","key":"1316_CR9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/BF01068419","volume":"15","author":"DJ Schuirmann","year":"1987","unstructured":"Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm. 1987;15(6):657\u201380.","journal-title":"J Pharmacokinet Biopharm"},{"key":"1316_CR10","unstructured":"Han S. Validation of Noncompartmental Analysis Performed by NonCompart R package. 2018."},{"issue":"2","key":"1316_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/pst.1979","volume":"19","author":"DA Noe","year":"2020","unstructured":"Noe DA. Performance characteristics of the adjusted r2 algorithm for determining the start of the terminal disposition phase and comparison with a simple r2 algorithm and a visual inspection method. Pharm Stat. 2020;19(2):88\u2013100.","journal-title":"Pharm Stat"},{"key":"1316_CR12","unstructured":"Pinheiro J, Bates D, DebRoy S, Sarkar D, Heisterkamp S, Van Willigen B, et al. nlme: Linear and Nonlinear Mixed Effects Models 3.1\u2013170 2026 [Available from: https:\/\/cran.r-project.org\/web\/packages\/nlme\/index.html."}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01316-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-026-01316-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01316-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:14:52Z","timestamp":1795043692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-026-01316-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":12,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["1316"],"URL":"https:\/\/doi.org\/10.1208\/s12248-026-01316-w","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"15 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"163"}}